(Q95818070)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450054%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

title

Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450054%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

1 reference

1 reference

1 reference

4

Manish Soneja

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450054%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

author name string

Praveen Tilangi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450054%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Devashish Desai

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450054%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

Adil Khan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450054%20AND%20SRC:MED&resulttype=core&format=json

30 May 2020

publication date

22 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450054%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

30 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32450054%20AND%20SRC:MED&resulttype=core&format=json

Hydroxychloroquine prophylaxis for COVID-19 contacts in India

30 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930430-8

7 January 2021

Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930430-8

7 January 2021

Can post-exposure prophylaxis for COVID-19 be considered as one of outbreak response strategies in long-term care hospitals?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930430-8

7 January 2021

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930430-8

7 January 2021

COVID-19: protecting health-care workers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930430-8

7 January 2021

Hydroxychloroquine is Not Associated with Hemolytic Anemia in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficient Patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930430-8

7 January 2021